{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:41:44Z","timestamp":1788295304222,"version":"build-2803163510"},"reference-count":44,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIGMS","award":["R01GM145845"],"award-info":[{"award-number":["R01GM145845"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The search for effective pain management solutions remains a critical challenge, especially amidst growing concerns over the use of conventional opioids. In the US, opioid-related mortality rates have surged to as many as 80 deaths per 100,000 people in some states, with an estimated economic burden of USD 1.5 trillion annually\u2014exceeding the gross domestic product (GDP) of most US industrial sectors. A remarkable breakthrough lies in the discovery that indole and oxindole alkaloids, produced by several genera within the plant Tribe Naucleeae, act on opioid receptors without activating the beta-arrestin-2 pathway, the primary driver of respiratory depression and overdose deaths. This systematic review explores the pharmacological properties, mechanisms of action, dosing considerations, interactions, and long-term effects of mitragynine and corynoxeine, alkaloids from the Southeast Asian plant Mitragyna speciosa (kratom) and others in the Tribe Naucleeae. Mitragynine, a partial opioid receptor agonist, and corynoxeine, known for its anti-inflammatory and neuroprotective effects, demonstrate significant therapeutic potential for managing diverse pain types\u2014including neuropathic, inflammatory, nociceptive, visceral, and central pain syndromes\u2014with a focus on cancer pain. Unlike traditional opioids, these compounds do not recruit beta-arrestin-2, avoiding key adverse effects such as respiratory depression, severe constipation, and rapid tolerance development. Their distinct pharmacological profiles make them innovative candidates for safer, non-lethal pain relief. However, challenges persist, including the unregulated nature of kratom products, inconsistencies in potency due to crude extract variability, potential for misuse, and adverse drug interactions. Addressing these issues requires establishing standardized quality control protocols, such as Good Manufacturing Practices (GMP), to ensure consistent potency and purity. Clear labeling requirements with dosage guidelines and warnings should be mandated to ensure safe use and prevent misuse. Furthermore, the implementation of regulatory oversight to monitor product quality and enforce compliance is essential. This review emphasizes the urgency of focused research to optimize dosing regimens, characterize the pharmacodynamic profiles of these alkaloids, and evaluate long-term safety. By addressing these gaps, the mitragynine- and corynoxeine-related drug classes can transition from promising plant-derived molecules to validated pharmacotherapeutic agents, potentially revolutionizing the field of pain management.<\/jats:p>","DOI":"10.3390\/ph18020222","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T08:53:41Z","timestamp":1738832021000},"page":"222","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Exploring the Therapeutic Potential of Mitragynine and Corynoxeine: Kratom-Derived Indole and Oxindole Alkaloids for Pain Management"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7311-0767","authenticated-orcid":false,"given":"Ahmed S.","family":"Alford","sequence":"first","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, Medical University of South Carolina, 70 President St., Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope L.","family":"Moreno","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, Medical University of South Carolina, 70 President St., Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-3405","authenticated-orcid":false,"given":"Menny M.","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, Medical University of South Carolina, 70 President St., Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1318-4438","authenticated-orcid":false,"given":"Cody F.","family":"Dickinson","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, Medical University of South Carolina, 70 President St., Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Hamann","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, Medical University of South Carolina, 70 President St., Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.2042-7158.1965.tb07599.x","article-title":"Alkaloids from Mitragyna speciosa (Korth.)","volume":"17","author":"Beckett","year":"1965","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Karunakaran, T., Ngew, K.Z., Zailan, A.A.D., Mian Jong, V.Y., and Abu Bakar, M.H. (2022). The chemical and pharmacological properties of mitragynine and its diastereomers: An insight review. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.805986"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.fitote.2013.01.018","article-title":"A review on indole alkaloids isolated from Uncaria rhynchophylla and their pharmacological studies","volume":"86","author":"Ndagijimana","year":"2013","journal-title":"Fitoterapia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/acscentsci.9b00141","article-title":"7-Hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects","volume":"5","author":"Kruegel","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/0115734099284849231212095407","article-title":"Comprehensive In Silico Analysis of Uncaria Tomentosa Extract: Chemical Profiling, Antioxidant Assessment, and CLASP Protein Interaction for Drug Design in Neurodegenerative Diseases","volume":"21","author":"Kumar","year":"2024","journal-title":"Curr. Comput.-Aided Drug Des."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jep.2015.06.011","article-title":"Medicinal uses, phytochemistry and pharmacology of the genus Uncaria","volume":"173","author":"Zhang","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1248\/bpb.31.2073","article-title":"Corynoxeine isolated from the hook of Uncaria rhynchophylla inhibits rat aortic vascular smooth muscle cell proliferation through the blocking of extracellular signal regulated kinase 1\/2 phosphorylation","volume":"31","author":"Kim","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00210-018-1536-y","article-title":"Endothelium-independent vasodilator effect of isocorynoxeine in vitro isolated from the hook of Uncaria rhynchophylla (Miquel)","volume":"391","author":"Li","year":"2018","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1254\/fpj.90.133","article-title":"Screening test for calcium antagonist in natural products. The active principles of Uncariae ramulus et uncus","volume":"90","author":"Yamahara","year":"1987","journal-title":"Nihon Yakurigaku Zasshi Folia Pharmacol. Jpn."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ellis, C.R., Racz, R., Kruhlak, N.L., Kim, M.T., Zakharov, A.V., Southall, N., Hawkins, E.G., Burkhart, K., Strauss, D.G., and Stavitskaya, L. (2020). Evaluating kratom alkaloids using PHASE. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0229646"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-011-9285-0","article-title":"Morphine and tumor growth and metastasis","volume":"30","author":"Afsharimani","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3892\/ijo.2017.4005","article-title":"Uncaria alkaloids reverse ABCB1-mediated cancer multidrug resistance","volume":"51","author":"Huang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13510","DOI":"10.1021\/acs.jmedchem.1c00726","article-title":"Activity of Mitragyna speciosa (\u201ckratom\u201d) alkaloids at serotonin receptors","volume":"64","author":"Obeng","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sun, Q., Zhao, N., Zhang, T.-J., Wang, S.-Y., Wang, L., and Meng, F.-H. (2024). Development of a novel UHPLC-MS\/MS method for the quantification of corynoxeine: Application to pharmacokinetics and tissue distribution studies in normal and chronic unpredictable mild stress-induced depression rats. J. Pharm. Biomed. Anal., 238.","DOI":"10.1016\/j.jpba.2023.115850"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acs.jmedchem.9b01465","article-title":"Investigation of the adrenergic and opioid binding affinities, metabolic stability, plasma protein binding properties, and functional effects of selected indole-based kratom alkaloids","volume":"63","author":"Obeng","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"114251","DOI":"10.1016\/j.bbr.2022.114251","article-title":"Analgesic effects of main indole alkaloid of kratom, mitragynine in acute pain animal model","volume":"439","author":"Mat","year":"2023","journal-title":"Behav Brain Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1016\/S0040-4020(98)00464-5","article-title":"New indole alkaloids from the leaves of Malaysian Mitragyna speciosa","volume":"54","author":"Takayama","year":"1998","journal-title":"Tetrahedron"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Huestis, M.A., Brett, M.A., Bothmer, J., and Atallah, R. (2024). Human Mitragynine and 7-Hydroxymitragynine Pharmacokinetics after Single and Multiple Daily Doses of Oral Encapsulated Dried Kratom Leaf Powder. Molecules, 29.","DOI":"10.3390\/molecules29050984"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1021\/acs.jmedchem.6b00748","article-title":"Mitragynine\/corynantheidine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism, which do not recruit \u03b2-arrestin-2","volume":"59","author":"Marrone","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s12094-018-1974-5","article-title":"The dual effect of morphine on tumor development","volume":"21","author":"Tuerxun","year":"2019","journal-title":"Clin. Transl. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s43440-023-00498-w","article-title":"Cannabidiol and mitragynine exhibit differential interactive effects in the attenuation of paclitaxel-induced mechanical allodynia, acute antinociception, and schedule-controlled responding in mice","volume":"75","author":"Ortiz","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"ref_22","unstructured":"Johnson, L.E., Balyan, L., Magdalany, A., Saeed, F., Salinas, R., Wallace, S., Veltri, C.A., Swogger, M.T., Walsh, Z., and Grundmann, O. (2020). Focus: Plant-based Medicine and Pharmacology: The Potential for kratom as an Antidepressant and Antipsychotic. Yale J. Biol. Med., 93."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kushida, H., Matsumoto, T., and Ikarashi, Y. (2021). Properties, pharmacology, and pharmacokinetics of active indole and oxindole alkaloids in uncaria hook. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.688670"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"114391","DOI":"10.1016\/j.jep.2021.114391","article-title":"Combinations of indole based alkaloids from Mitragyna speciosa (Kratom) and cisplatin inhibit cell proliferation and migration of nasopharyngeal carcinoma cell lines","volume":"279","author":"Domnic","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Annuar, N.A.K., Azlan, U.K., Mediani, A., Tong, X., Han, R., Al-Olayan, E., Baharum, S.N., Bunawan, H., Sarian, M.N., and Hamezah, H.S. (2024). An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine. Biomed. Pharmacother., 171.","DOI":"10.1016\/j.biopha.2024.116134"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ramachandram, D.S., Damodaran, T., Zainal, H., Murugaiyah, V., and Ramanathan, S. (2020). Pharmacokinetics and pharmacodynamics of mitragynine, the principle alkaloid of Mitragyna speciosa: Present knowledge and future directions in perspective of pain. J. Basic Clin. Physiol. Pharmacol., 31.","DOI":"10.1515\/jbcpp-2019-0138"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ajp.2019.05.016","article-title":"Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom (Mitragyna speciosa): A systematic review","volume":"43","author":"Ya","year":"2019","journal-title":"Asian J. Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.1109237","article-title":"Transduction of receptor signals by \u03b2-arrestins","volume":"308","author":"Lefkowitz","year":"2005","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1021\/jacs.6b00360","article-title":"Synthetic and receptor signaling explorations of the mitragyna alkaloids: Mitragynine as an atypical molecular framework for opioid receptor modulators","volume":"138","author":"Kruegel","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2021.11.002","article-title":"The effect of mitragynine on extracellular activity of brain dopamine and its metabolites","volume":"178","author":"Yusoff","year":"2022","journal-title":"Brain Res. Bull."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/10550887.2021.1950263","article-title":"Kratom use disorder: A primer for primary care physicians","volume":"40","author":"Groff","year":"2022","journal-title":"J. Addict. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/02791072.2018.1562133","article-title":"Kratom withdrawal: A systematic review with case series","volume":"51","author":"Stanciu","year":"2019","journal-title":"J. Psychoact. Drugs"},{"key":"ref_33","first-page":"5810","article-title":"The effects on motor behaviour and short-term memory tasks in mice following an acute administration of Mitragyna speciosa alkaloid extract and mitragynine","volume":"5","author":"Hazim","year":"2011","journal-title":"J. Med. Plants Res."},{"key":"ref_34","first-page":"39","article-title":"Effects of the extracts from Mitragyna speciosa Korth. leaves on analgesic and behavioral activities in experimental animals","volume":"29","author":"Reanmongkol","year":"2007","journal-title":"Songklanakarin J. Sci. Technol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"116779","DOI":"10.1016\/j.jep.2023.116779","article-title":"Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects","volume":"317","author":"Grundmann","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/cpt.2891","article-title":"Clinical assessment of the drug interaction potential of the psychotropic natural product kratom","volume":"113","author":"Tanna","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Henningfield, J.E., Wang, D.W., and Huestis, M.A. (2022). Kratom Abuse Potential 2021: An Updated Eight Factor Analysis. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.775073"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1021\/acschemneuro.1c00149","article-title":"Kratom alkaloids as probes for opioid receptor function: Pharmacological characterization of minor indole and oxindole alkaloids from kratom","volume":"12","author":"Chakraborty","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e14280","DOI":"10.7717\/peerj.14280","article-title":"Exploring of cardiac autonomic activity with heart rate variability in long-term kratom (Mitragyna speciosa Korth.) users: A preliminary study","volume":"10","author":"Saengmolee","year":"2022","journal-title":"PeerJ"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lu, J., Wei, H., Wu, J., Jamil, M.F.A., Tan, M.L., Adenan, M.I., Wong, P., and Shim, W. (2014). Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0115648"},{"key":"ref_41","unstructured":"St\u00e9phane, F.F.Y., Jules, B.K.J., Batiha, G.E.-S., Ali, I., and Bruno, L.N. (2021). Extraction of bioactive compounds from medicinal plants and herbs. Natural Medicinal Plants, InTech Open."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.forsciint.2019.04.009","article-title":"A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products","volume":"299","author":"Fowble","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/dta.2746","article-title":"Development, validation, and application of an LC\u2013MS\/MS method for mitragynine and 7-hydroxymitragynine analysis in hair","volume":"12","author":"Meier","year":"2020","journal-title":"Drug Test. Anal."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Farkas, D.J., Cooper, Z.D., Heydari, L.N., Hughes, A.C., Rawls, S.M., and Ward, S.J. (2023). Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in Therapy. Cannabis Cannabinoid Res.","DOI":"10.1089\/can.2023.0064"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/2\/222\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:28:05Z","timestamp":1760027285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/2\/222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["ph18020222"],"URL":"https:\/\/doi.org\/10.3390\/ph18020222","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]}}}